Admedus Limited announced the appointment of Kiran Bhirangi as its Chief Medical Officer. Bhirangi will be responsible for accelerating the research projects that will generate new product launches in key areas, further emphasising the company's strategic focus on growth opportunities. He will also take a leading role in driving the TAVR (Transcatheter Aortic Valve Replacement) and SAVR (Surgical Aortic Valve Replacement) projects as well as other catheter-based projects to expand the ADAPT portfolio of products. In addition, Bhirangi will be responsible for coordinating global medical affairs strategies, clinical compliance, global clinical study programs, and developing company's clinical publications and scientific presentations strategies.